Relugolix-d6
Relugolix-d6 is deuterium labeled Relugolix. Relugolix (TAK-385) ?is a potent, orally active, nonpeptidic gonadotropin-releasing hormone (GnRH) antagonist. Relugolix possesses high affinity and potent antagonistic activity for human receptor (binding IC50=0.33 nM) and monkey receptor (IC50=0.32 nM) compared with TAK-013. Relugolix is used for the study of sex-hormone-dependent diseases, such as including endometriosis, uterine fibroids and prostate cancer et al[2].
Product Specifications
Product Name Alternative
TAK-385-d6
UNSPSC
12352005
Target
GnRH Receptor; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
GPCR/G Protein; Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Endocrinology
Purity
98.82
Solubility
10 mM in DMSO
Smiles
O=C(NOC)NC1=CC=C(C(S2)=C(CN(C([2H])([2H])[2H])C([2H])([2H])[2H])C(C(N3C4=NN=C(OC)C=C4)=O)=C2N(CC5=C(F)C=CC=C5F)C3=O)C=C1
Molecular Formula
C29H21D6F2N7O5S
Molecular Weight
629.67
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
